Cargando…

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children

The present study aimed to establish population pharmacokinetic models of latamoxef, as well as its R- and S-epimers, and generate findings to guide the individualized administration of latamoxef in pediatric patients. A total of 145 in-hospital children aged 0.08–10.58 years old were included in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Sun, Dan, Mei, Yan, Wu, Sanlan, Li, Xinlin, Li, Sichan, Wang, Jun, Gao, Liuliu, Xu, Hua, Tuo, Yali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146031/ https://www.ncbi.nlm.nih.gov/pubmed/35631619 http://dx.doi.org/10.3390/pharmaceutics14051033

Ejemplares similares

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
por: Li, SiChan, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
por: Li, SiChan, et al.
Publicado: (2022)

Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection
por: Hagiya, Hideharu, et al.
Publicado: (2015)

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes
por: Xin, Yingying, et al.
Publicado: (2022)

The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus
por: Mu, Dan, et al.
Publicado: (2020)

Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report
por: Zhang, Ruo-Ying, et al.
Publicado: (2022)

Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial
por: Qi, Hui, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
por: Jin, Zi-bin, et al.
Publicado: (2022)

Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients
por: Komatsu, Toshiaki, et al.
Publicado: (2015)

Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis
por: Wu, Hailan, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus
por: Li, Ling, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
por: Fan, Yaxin, et al.
Publicado: (2022)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
por: Komatsu, Toshiaki, et al.
Publicado: (2016)

Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
por: Cao, Peng, et al.
Publicado: (2022)

Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations
por: Zhai, Jingchen, et al.
Publicado: (2022)

Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
por: Yuan, Jinjie, et al.
Publicado: (2021)

Ornidazole Transfer into Colostrum and Assessment of Exposure Risk for Breastfeeding Infant: A Population Pharmacokinetic Analysis
por: Li, Sichan, et al.
Publicado: (2023)

Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics
por: Liu, Stephanie N., et al.
Publicado: (2021)

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
por: Paule, Ines, et al.
Publicado: (2011)

Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen
por: Thorsted, Anders, et al.
Publicado: (2019)

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
por: Wang, Yifan, et al.
Publicado: (2023)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
por: Jager, Nynke G L, et al.
Publicado: (2020)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
por: Niu, Chang-He, et al.
Publicado: (2020)

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients
por: Kato, Hideo, et al.
Publicado: (2021)

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
por: Zhi, Li-Juan, et al.
Publicado: (2018)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
por: Chen, Xiao, et al.
Publicado: (2021)

Pharmacokinetics and Optimal Dosing of Phenobarbital
por: Shareef, Safiullah, et al.
Publicado: (2018)

Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog
por: Jeunesse, Elisabeth C, et al.
Publicado: (2013)

Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers
por: Ferguson, Kaitlyn M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90rvqmsn17ov6h5ao26j70b6r3